26 Followers on Owler

Nxera

is a Japan-based biopharmaceutical company that develops and commercializes medicines for the treatments of diseases such as neurology and immunology conditions... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

Nxera

is a Japan-based biopharmaceutical company that develops and commercializes medicines for the treatments of diseases such as neurology and immunology conditions... Read more
Nxera President & CEO: Chris Cargill

President & CEO

Chris Cargill

CEO Approval Rating

90/100

1990

PublicTokyo Stock Exchange4565

Pharmaceuticals & Biotechnology
Pharmaceuticals

Annual Revenue
$113.8M
Employees
364
Funding
$200M
Acquisitions
1

News

Partnership
Jan 14, 2025
centralcharts
Nxera Pharma Provides Update on Neurocrine's Progress with its Partnered Muscarinic Agonist Portfolio
Conference Presentation
Dec 23, 2024
Marketscreener
Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nxera Competitors

1Janssen
2ZyVersa
3IFM Therapeutics
4Alector
5SanBio Co., Ltd.
6NexImmune
7Walden
8Jounce
9Reata Pharmaceuticals
10Biogen
Unlock 12 + competitors